Hormel Foods Q1 Results and Turkey Business Sale
Analysis based on 8 articles · First reported Feb 17, 2026 · Last updated Feb 18, 2026
The market is likely to react positively to Hormel Foods' preliminary Q1 results, which show organic net sales growth and reaffirmed full-year guidance. The sale of the whole-bird turkey business indicates strategic portfolio management, which is generally viewed favorably.
Hormel Foods announced its preliminary first quarter fiscal 2026 results, reporting approximately $3 billion in net sales with 2% organic net sales growth and diluted earnings per share of $0.33. The company also reaffirmed its fiscal 2026 organic net sales and adjusted diluted earnings per share guidance. Additionally, Hormel Foods entered into a definitive agreement to sell its whole-bird turkey business to Life Science Innovations, a move described as part of its ongoing portfolio shaping efforts. The transaction is expected to close by the end of the second fiscal quarter of 2026, with minimal estimated impact on fiscal 2026 guidance. Jeff Ettinger, interim CEO, expressed satisfaction with the results, and both he and John Ghingo, president, are scheduled to present at the 2026 CAGNY conference.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard